APA

Revicki D. A., Swartz C., Wu A. W., Haubrich R. & Collier A. C. (20000302). Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. : Antiviral therapy.

Chicago

Revicki D A, Swartz C, Wu A W, Haubrich R and Collier A C. 20000302. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. : Antiviral therapy.

Harvard

Revicki D. A., Swartz C., Wu A. W., Haubrich R. and Collier A. C. (20000302). Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. : Antiviral therapy.

MLA

Revicki D A, Swartz C, Wu A W, Haubrich R and Collier A C. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3. : Antiviral therapy. 20000302.